FDA Asks Pfizer To Test Additional Course Of Paxlovid Among People Who Experience COVID-19 Rebound

Reuters (8/19, Leo) reported the FDA “has asked Pfizer Inc to test the effects of an additional course of its antiviral Paxlovid among people who experience a rebound in COVID-19 after treatment, the regulator said on Friday.” The company “must produce th...